
Opticent Profile last edited on: 11/15/2017
CAGE: 7B8G5
UEI: ZJJSNNW9BY46
Business Identifier: Non-invasive medical imaging instrument that rapidly and reliably assesses retinal health Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
820 Davis Street Unit 128
Evanston, IL 60201
Evanston, IL 60201
(847) 491-7167 |
administrator@opticenthealth.com |
www.opticenthealth.com |
Location: Single
Congr. District: 09
County: Cook
Congr. District: 09
County: Cook
Public Profile
With extensive ties to Northwestern University, Opticent is organzied around ttenpting to make personalized medicine a scalable reality through next generation imaging and fabrication technologies. The firm is forcused on commercializing a novel non-invasive non-contact diagnostic instrument for the early detection of multiple chronic diseases; and production of high quality, affordable and individually patient specific 3D printed medical implants. The effort is to provide ophthalmologists with a non-invasive medical imaging instrument that rapidly and reliably assesses retinal health, empowering them to better diagnose and manage a variety of chronic, incurable diseases.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2023 | 1 | NIH | $253,012 | |
Project Title: Extraordinary Dispersion Engineering In Enabling Ultrafast Swept Source visiblelight Optical Coherence Tomography | ||||
2023 | 2 | NIH | $2,899,787 | |
Project Title: Clinical Optical Coherence Tomography for Retinal Metabolic Imaging | ||||
2017 | 1 | NIH | $225,116 | |
Project Title: Method for accurate retinal oxygen metabolic rate extraction | ||||
2016 | 1 | NSF | $224,850 | |
Project Title: Low-cost light source development for functional retinal imaging |
Key People / Management
Kieren Jay Patel -- CEO
Wenzhong Liu -- Head of Product Engineering
Andrew Joseph Radosevich
Cheng Sun -- Co-Founder. Head of Advanced Fabrication
Hao F Zhang -- Co-Founder
Wenzhong Liu -- Head of Product Engineering
Andrew Joseph Radosevich
Cheng Sun -- Co-Founder. Head of Advanced Fabrication
Hao F Zhang -- Co-Founder
Company News
There are no news available.